Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers

AAPS PharmSciTech

Volumn 11, Issue 3, 2010, Pages 1147-1151

  Amani, Amir ^a,b   York, Peter ^a   Chrystyn, Henry ^c   Clark, Brian J ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

budesonide; in vitro characterisation; microemulsion; nanoemulsion; nebulizer; suspension

Indexed keywords

BECLOSPIN; BUDESONIDE; UNCLASSIFIED DRUG;

AEROSOL; ARTICLE; DILUTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; IN VITRO STUDY; NANOEMULSION; NEBULIZER; PARTICLE SIZE; PERFORMANCE; PRIORITY JOURNAL; SUSPENSION;

ADMINISTRATION, INHALATION; AEROSOLS; DRUG COMPOUNDING; EMULSIONS; MATERIALS TESTING; NANOPARTICLES; NEBULIZERS AND VAPORIZERS; RESPIRATORY SYSTEM AGENTS;

EID: 78649903852     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9486-9     Document Type: Article

References (23)

1. M Knoch M Keller 2005 The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems Expert Opin Drug Deliv 2 377 390 1:CAS:528:DC%2BD2MXjsFant78%3D 10.1517/17425247.2.2.377 16296761 (Pubitemid 41130890)
2. VB Patravale AA Date RM Kulkarni 2004 Nanosuspensions: a promising drug delivery strategy J Pharm Pharmacol 56 827 840 1:CAS:528:DC%2BD2cXmtFGqtL8%3D 10.1211/0022357023691 15233860 (Pubitemid 38885975)
3. WD Bennet KL Zeman WC Kang MS Schechter 1997 Extrathoracic deposition of inhaled, coarse particles (4.5 μm) in children vs. adults Ann Occup Hyg 41 497 502
4. K Nikander M Turpeinen P Wollmer 1999 The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension J Aerosol Med 12 47 53 1:STN:280:DyaK1MznvVKjtA%3D%3D 10.1089/jam.1999.12.47 10539706
5. MJ Lawrence GD Rees 2000 Microemulsion-based media as novel drug delivery systems Adv Drug Deliv Rev 45 89 121 1:CAS:528:DC%2BD3cXosFertb4%3D 10.1016/S0169-409X(00)00103-4 11104900
6. S Tenjarla 1999 Microemulsions: an overview and pharmaceutical applications Crit Rev Ther Drug Carrier Syst 16 461 521 1:CAS:528: DC%2BD3cXjs1SjsA%3D%3D 10635455
7. H Courrier MP Krafft S Nakamura O Shibata T Vandamme 2003 Water-in-fluorocarbon reverse emulsion as a pulmonary drug delivery system: effect on the lung as modelled by a phospholipid monolayer. S.T.P Pharma Pratiques 13 22 26 1:CAS:528:DC%2BD3sXjslSltro%3D
8. N Patel M Marlow MJ Lawrence 2003 Formation of non-ionic fluorinated surfactant microemulsions in hydrofluorocarbon 134a (HFC 134a) J Colloid Interface Sci 258 345 353 1:CAS:528:DC%2BD3sXhsFOns7w%3D 10.1016/S0021-9797(02) 00072-3 12618104 (Pubitemid 36293366)
9. N Patel M Marlow MJ Lawrence 2003 Fluorinated ionic surfactant microemulsions in hydrofluorocarbon 134a (HFC 134a) J Colloid Interface Sci 258 354 362 1:CAS:528:DC%2BD3sXhsFOns7o%3D 10.1016/S0021-9797(02)00071-1 12618105 (Pubitemid 36293367)
10. ML Sommerville AJ Hickey 2003 Aerosol generation by metered-dose inhalers containing dimethyl ether/propane inverse microemulsions AAPS PharmSciTech 4 455 461 10.1208/pt040458
11. ML Sommerville CS Johnson JB Cain F Rypacek AJ Hickey 2002 Lecithin microemulsions in dimethyl ether and propane for the generation of pharmaceutical aerosols containing polar solutes Pharm Dev Technol 7 273 288 1:CAS:528:DC%2BD38XmvFOns70%3D 10.1081/PDT-120005724 12229259 (Pubitemid 34983119)
12. A Amani P York H Chrystyn BJ Clark DQ Do 2008 Determination of factors controlling the particle size in nanoemulsions using artificial neural networks Eur J Pharm Sci 35 42 51 1:CAS:528:DC%2BD1cXpvF2qs74%3D 10.1016/j.ejps.2008.06. 002 18617002
13. A Vaghi E Berg S Liljedahl JO Scensson 2005 In vitro comparison of nebulised budesonide (Pulmicort Respules®) and beclomethasone dipropionate (Clenil® per Aerosol) Pulm Pharmacol 18 151 153 1:CAS:528: DC%2BD2MXis1Sktw%3D%3D 10.1016/j.pupt.2004.10.004 (Pubitemid 40092666)
14. European committee for standardization (CEN). Respiratory therapy equipment-Part 1: nebulizing systems and their components. Brussles: CEN-CENELEC Management Centre; 2001.
15. VL Silkstone JH Dennis CA Pieron H Chrystyn 2002 An investigation of in vitro/in vivo correlation for salbutamol nebulized by eight systems J Aerosol Med 15 251 259 1:CAS:528:DC%2BD38XnsVSlt7Y%3D 10.1089/089426802760292591 12396413
16. M Almeziny BJ Clark 2007 High performance liquid chromatography assay method for simultaneous quantitation of formoterol and the two epimers of budesonide J Pharm Pharmacol 59 Suppl. 1 76
17. EB Berg RJ Picard 2009 In vitro delivery of budesonide from 30 jet nebulizer/compressor combinations using infant and child breathing patterns Respir Care 54 1671 1678 19961633
18. A Amani H Chrystyn BJ Clark ME Abdelrahim P York 2009 Evaluation of supercritical fluid engineered budesonide powder for respiratory delivery using nebulisers J Pharm Pharmacol 61 1625 1630 1:CAS:528:DC%2BC3cXitFGqsrs%3D 10.1211/jpp.61.12.0006 19958584
19. AH Kendrick EC Smith RS Wilson 1997 Selecting and using nebuliser equipment Thorax 52 2 S92 S101 10.1136/thx.52.2008.S92 9155861
20. OS Usmani MF Biddiscombe PJ Barnes 2005 Regional lung deposition and bronchodilator response as a function of 2-agonist particle size Am J Respir Crit Care Med 172 1497 1504 10.1164/rccm.200410-1414OC 16192448 (Pubitemid 43076536)
21. Amani A. Design, characterisation and in vitro aerosolisation performance of nanoemulsion for nebulisation of hydrophobic drugs. Ph.D. thesis, University of Bradford, 2008
22. J Riedler CF Robertson 1994 Effect of tidal volume on the output and particle size distribution of hypertonic saline from an ultrasonic nebulizer Eur Respir J 7 998 1002 1:STN:280:DyaK2czis12isA%3D%3D 8050559
23. M Abdelrahim H Chrsytyn 2008 Aerodynamic characteristics of nebulised terbutaline sulphate using the next generation impactor (NGI) and CEN method J Aerosol Med Pulm Drug Deliv 22 19 28